Profil
Ranjan Batra currently works at Dyne Therapeutics, Inc., as Chief Scientific Officer from 2025 and Lexeo Therapeutics, Inc., as Vice President-Research & Translation.
Dr. Batra also formerly worked at Locanabio, Inc., as SVP-Research & Development.
Dr. Batra received his doctorate degree from the University of Florida.
Postes actifs de Ranjan Batra
| Sociétés | Poste | Début |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 28/04/2025 |
Anciens postes connus de Ranjan Batra
| Sociétés | Poste | Fin |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Corporate Officer/Principal | 02/04/2025 |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Ranjan Batra
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technology Services |
Lexeo Therapeutics Inc
Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
















